Full Press Release Details
Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference.
RARE
Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Key Takeaway: Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Price reaction · baseline $22.51 (2026-01-09 close) · clean, no other RARE news in the window
day 0 close · peak
+8.3%
day 1
+7.1%
day 3
+4.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia